← Eichor
Study identifier: NCT07347821 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty

Condition: Total Hip Arthroplasty (THA) · Total Knee Arthroplasty (TKA) · Hip Osteoarthritis  ·  Sponsor: Medical University of Warsaw

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this observational study is to determine content of rare metals and other elements, along with the levels of selected immunological parameters, in the tissue of the hip or knee joint in the course of degenerative diseases. Determining potential disturbances in the levels or functions of these parameters may in the future contribute to improving treatment - for example, through supplementation of deficient metals or modulation at the immunological level. The main question it aims to answer is: Are selected rare metals, trace elements and other selected immunological parameters lowered in the tissue of the hip or knee joint as well as in serum in the course of osteoarthritis?

This description comes directly from the study's public registry record.

Talk to the study team

Artur Stolarczyk, Professor  ·  +48224735218  ·  artur.stolarczyk@wum.edu.pl

Always discuss trial participation with your own doctor first.

Locations (1)

Szpital Powiatowy im. M. Skłodowskiej-CurieOstrów Mazowiecka, Masovian Voivodeship, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07347821